Growth hormone secretion is diminished and tightly controlled in humans enriched for familial longevity

Aging Cell

Volumn 15, Issue 6, 2016, Pages 1126-1131

  van der Spoel, Evie ^a   Jansen, Steffy W ^a   Akintola, Abimbola A ^a   Ballieux, Bart E ^a   Cobbaert, Christa M ^a   Slagboom, P Eline ^a   Blauw, Gerard Jan ^a   Westendorp, Rudi G J ^a,b   Pijl, Hanno ^a   Roelfsema, Ferdinand ^a   van Heemst, Diana ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

approximate entropy; familial longevity; growth hormone; hormone secretion; human; IGF 1

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; LONGEVITY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SLEEP PARAMETERS; WAIST CIRCUMFERENCE;

EID: 84994339210     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12519     Document Type: Article

References (41)

1. Akintola AA, Jansen SW, Wilde RB, Hultzer G, Rodenburg R, van Heemst D (2015) A simple and versatile method for frequent 24 h blood sample collection in healthy older adults. MethodsX. 2, 33–38.
2. Arce VM, Devesa P, Devesa J (2013) Role of growth hormone (GH) in the treatment on neural diseases: from neuroprotection to neural repair. Neurosci. Res. 76, 179–186.
3. Bartke A (2011) Pleiotropic effects of growth hormone signaling in aging. Trends Endocrinol. Metab. 22, 437–442.
4. Bartke A, Sun LY, Longo V (2013) Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol. Rev. 93, 571–598.
5. Besson A, Salemi S, Gallati S, Jenal A, Horn R, Mullis PS, Mullis PE (2003) Reduced longevity in untreated patients with isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 88, 3664–3667.
6. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A (1996) Dwarf mice and the ageing process. Nature 384, 33.
7. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28, 193–213.
8. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ (2000) Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141, 2608–2613.
9. Dimaraki EV, Jaffe CA (2006) Role of endogenous ghrelin in growth hormone secretion, appetite regulation and metabolism. Rev. Endocr. Metab. Disord. 7, 237–249.
10. Florini JR, Ewton DZ, Coolican SA (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 17, 481–517.
11. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl Acad. Sci. USA 98, 6736–6741.
12. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19, 717–797.
13. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P, Longo VD (2011) Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3, 70ra13.
14. van Heemst D, Beekman M, Mooijaart SP, Heijmans BT, Brandt BW, Zwaan BJ, Slagboom PE, Westendorp RG (2005) Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 4, 79–85.
15. Jansen SW, Akintola AA, Roelfsema F, van der Spoel E, Cobbaert CM, Ballieux BE, Egri P, Kvarta-Papp Z, Gereben B, Fekete C, Slagboom PE, van der Grond J, Demeneix BA, Pijl H, Westendorp RGJ, van Heemst D (2015) Human longevity is characterised by high thyroid stimulating hormone secretion without altered energy metabolism. Sci. Rep. 5, 11525.
16. Kiaris H, Chatzistamou I, Papavassiliou AG, Schally AV (2011) Growth hormone-releasing hormone: not only a neurohormone. Trends Endocrinol. Metab. 22, 311–317.
17. Laron Z (2002) Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity. Novartis Found. Symp. 242, 125–137.
18. Liu PY, Keenan DM, Kok P, Padmanabhan V, O'Byrne KT, Veldhuis JD (2009) Sensitivity and specificity of pulse detection using a new deconvolution method. Am. J. Phys. Endocrinol. Metab. 297, E538–E544.
19. Longo VD, Finch CE (2003) Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299, 1342–1346.
20. de Mello-Coelho V, Gagnerault MC, Souberbielle JC, Strasburger CJ, Savino W, Dardenne M, Postel-Vinay MC (1998) Growth hormone and its receptor are expressed in human thymic cells. Endocrinology 139, 3837–3842.
21. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G (2010) Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit. Care Med. 38, 1021–1029.
22. Orme SM, Mcnally RJQ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. J. Clin. Endocrinol. Metab. 83, 2730–2734.
23. Pincus SM (1991) Approximate entropy as a measure of system-complexity. Proc. Natl Acad. Sci. USA 88, 2297–2301.
24. Pincus SM, Gevers EF, Robinson ICAF, VandenBerg G, Roelfsema F, Hartman ML, Veldhuis JD (1996) Females secrete growth hormone with more process irregularity than males in both humans and rats. Am. J. Phys. Endocrinol. Metab. 270, E107–E115.
25. Pincus SM, Hartman ML, Roelfsema F, Thorner MO, Veldhuis JD (1999) Hormone pulsatility discrimination via coarse and short time sampling. Am. J. Phys. Endocrinol. Metab. 277, E948–E957.
26. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stokvis-Brantsma WH, Wit JM (2001) Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J. Clin. Endocrinol. Metab. 86, 2459–2464.
27. Roelfsema F, Biermasz NR, Veldhuis JD (2002) Pulsatile, nyctohemeral and entropic characteristics of GH secretion in adult GH-deficient patients: selectively decreased pulsatile release and increased secretory disorderliness with preservation of diurnal timing and gender distinctions. Clin. Endocrinol. 56, 79–87.
28. Roenneberg T, Wirz-Justice A, Merrow M (2003) Life between clocks: daily temporal patterns of human chronotypes. J. Biol. Rhythms 18, 80–90.
29. Ross HA, Lentjes EW, Menheere PM, Sweep CG (2014) Harmonization of growth hormone measurement results: the empirical approach. Clin. Chim. Acta 432, 72–76.
30. Rozing MP, Westendorp RGJ, Frolich M, de Craen AJM, Beekman M, Heijmans BT, Mooijaart SP, Blauw GJ, Slagboom PE, van Heemst D (2009) Human insulin/IGF-1 and familial longevity at middle age. Aging-Us. 1, 714–722.
31. Sattler FR (2013) Growth hormone in the aging male. Best Pract. Res. Clin. Endocrinol. Metab. 27, 541–555.
32. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N, Cohen P (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl Acad. Sci. USA 105, 3438–3442.
33. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A (2005) Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol. Aging 26, 929–937.
34. Takahash Y, Kipnis DM, Daughada WH (1968) Growth hormone secretion during sleep. J. Clin. Invest. 47, 2079–2790.
35. Veldhuis JD, Straume M, Iranmanesh A, Mulligan T, Jaffe C, Barkan A, Johnson ML, Pincus S (2001) Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am. J. Phys. Regul. Integr. Comp. Phys. 280, R721–R729.
36. Veldhuis JD, Roelfsema F, Keenan DM, Pincus S (2011) Gender, age, body mass index, and IGF-I individually and jointly determine distinct GH dynamics: analyses in one hundred healthy adults. J. Clin. Endocrinol. Metab. 96, 115–121.
37. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov. 2, 999–1017.
38. Westendorp RGJ, van Heemst D, Rozing MP, Frolich M, Mooijaart SP, Blauw GJ, Beekman M, Heijmans BT, de Craen AJM, Slagboom PE (2009) Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: the Leiden Longevity Study. J. Am. Geriatr. Soc. 57, 1634–1637.
39. Wolf E, Kahnt E, Ehrlein J, Hermanns W, Brem G, Wanke R (1993) Effects of long-term elevated serum levels of growth-hormone on life expectancy of mice – lessons from transgenic animal-models. Mech. Ageing Dev. 68, 71–87.
40. Zadik Z, Chalew SA, Mccarter RJ, Meistas M, Kowarski AA (1985) The influence of age on the 24-hour integrated concentration of growth-hormone in normal individuals. J. Clin. Endocrinol. Metab. 60, 513–516.
41. Zavada A, Gordijn MC, Beersma DG, Daan S, Roenneberg T (2005) Comparison of the Munich chronotype questionnaire with the Horne-Ostberg's morningness-eveningness score. Chronobiol. Int. 22, 267–278.